GHRP-2, or growth hormone-releasing peptide-2, is a synthetic growth-hormone secretagogue that has been investigated for its ability to stimulate endogenous growth hormone release. Human studies have examined GHRP-2 in diagnostic GH stimulation, endocrine physiology, and related research, but those study protocols should not be interpreted as universal reconstitution instructions or treatment recommendations.
✓ Human Research GH Secretagogue ⚠ Investigational / Regulatory Limitations
Conceptual research illustration — the peptide and receptor artwork is not an exact molecular structure or binding model.
Research Snapshot
CompoundGHRP-2
Class Synthetic hexapeptide / GH secretagogue
Research Category Endocrinology / GH signaling
Regulatory Status No FDA-approved GHRP-2 drug product identified
Human Evidence Human studies available
Vial Quantities No standardized quantity established in sources reviewed
Last Reviewed September 10, 2026
Concentration Mathematics
How Much BAC Water for GHRP-2?
Short answer: there is no single universal BAC-water volume for GHRP-2 established by the authoritative sources reviewed. The required liquid volume depends on the total quantity of peptide and the target concentration used for a particular research protocol. Changing the liquid volume changes concentration; it does not change the total amount of peptide contained in the vial.
GHRP-2 Mathematical Concentration Examples
Because authoritative sources reviewed for this page do not establish a universal commercial GHRP-2 vial size, the 5 mg and 10 mg rows below are hypothetical calculation examples, not claims about standardized GHRP-2 packaging.
Hypothetical Vial Quantity
1 mL
2 mL
2.5 mL
3 mL
5 mL
5 mg GHRP-2
5 mg/mL
2.5 mg/mL
2 mg/mL
1.67 mg/mL
1 mg/mL
10 mg GHRP-2
10 mg/mL
5 mg/mL
4 mg/mL
3.33 mg/mL
2 mg/mL
Important: These are mathematical concentration examples only. They are not manufacturer instructions, FDA-approved dosing, clinical treatment protocols, or BacScience recommendations.
Search Intent Answer
How Much BAC Water Should Be Added to GHRP-2?
The scientifically correct answer is that the volume cannot be selected from the compound name alone. First identify the actual quantity of GHRP-2 in the vial and then determine the concentration required by the applicable research protocol or product documentation. The mathematical relationship is straightforward.
How Much BAC Water for 5 mg GHRP-2?
For a hypothetical 5 mg quantity, 1 mL would produce 5 mg/mL, 2 mL would produce 2.5 mg/mL, 2.5 mL would produce 2 mg/mL, and 5 mL would produce 1 mg/mL.
These values describe concentration mathematics only. They do not establish which concentration should be used experimentally.
How Much BAC Water for 10 mg GHRP-2?
For a hypothetical 10 mg quantity, 1 mL would produce 10 mg/mL, 2 mL would produce 5 mg/mL, 2.5 mL would produce 4 mg/mL, 3 mL would produce approximately 3.33 mg/mL, and 5 mL would produce 2 mg/mL.
Again, these are calculation examples rather than recommended reconstitution volumes.
How Does BAC-Water Volume Change GHRP-2 Concentration?
For a fixed amount of GHRP-2, increasing the liquid volume decreases the concentration because the same quantity of peptide is distributed through a larger volume. Decreasing the liquid volume increases the mathematical concentration.
How Do You Calculate GHRP-2 Concentration?
Concentration = Total vial quantity ÷ Liquid volume
For example, if a hypothetical vial contains 10 mg and the final liquid volume is 2 mL:
10 mg ÷ 2 mL = 5 mg/mL This is a mathematical concentration, not a clinical dose.
Compound Definition
What Is GHRP-2?
GHRP-2 stands for growth hormone-releasing peptide-2. It is a synthetic peptide belonging to the growth hormone secretagogue class. Early human research demonstrated that synthetic growth hormone-releasing peptides can stimulate endogenous GH secretion.
GHRP-2 has subsequently been studied in humans as a provocative or diagnostic stimulus for growth hormone secretion and in investigations of endocrine physiology.
GHRP-2 is distinct from growth hormone itself and from growth-hormone-releasing hormone (GHRH). It acts through the growth hormone secretagogue receptor pathway.
Entity definition: GHRP-2 is a synthetic growth hormone secretagogue that has been investigated primarily for its ability to stimulate endogenous GH release.
Mechanism
How GHRP-2 Works
GHRP-2 belongs to the growth hormone secretagogue family. Research indicates that GHRP-2 interacts with the growth hormone secretagogue receptor (GHS-R), a receptor also involved in ghrelin signaling. Activation of this pathway can stimulate GH secretion.
01
GHRP-2 Signal
GHRP-2 acts as a synthetic ligand within the growth hormone secretagogue system.
02
GHS-R Signaling
The growth hormone secretagogue receptor is part of the ghrelin/GHS-R signaling system involved in endocrine and metabolic physiology.
03
GH Release
Human studies have demonstrated stimulation of endogenous GH secretion after GHRP-2 administration.
Research distinction: stimulation of GH secretion in an experimental study does not by itself establish a therapeutic indication, an appropriate chronic dose, or a recommended reconstitution concentration.
Research Landscape
What Is GHRP-2 Being Studied For?
GH
Growth Hormone Physiology
GHRP-2 has been used experimentally to investigate the regulation and responsiveness of endogenous growth hormone secretion.
DX
Growth Hormone Deficiency Testing
Human studies have evaluated GHRP-2 as a provocative stimulus for identifying impaired GH responses, including studies involving adults with suspected GH deficiency.
EN
Endocrine Research
Researchers have examined GH responses in different physiological and clinical populations, including effects associated with age, adiposity, illness, and endocrine function.
AP
Appetite & Energy-Homeostasis Research
Human research has also examined whether GHRP-2 can influence appetite, reflecting overlap between GH-secretagogue and ghrelin signaling.
Human Evidence
Human Clinical Research
GHRP-2 has been investigated in controlled human studies. The evidence includes acute GH-stimulation studies, provocative testing for GH deficiency, appetite research, and longer experimental administration. The existence of these studies does not mean the studied dose, administration route, or frequency should be treated as a general recommendation.
Clinical-dose distinction: published study doses are experimental parameters selected for a specific research question. They are not automatically equivalent to a recommended human dose or a reconstitution instruction.
Published Human Studies
Doses Studied in Published Research
The following table summarizes selected human research. These are reported research doses, NOT BacScience dosage recommendations.
Study
Population
Dose Studied
Route
Frequency
Duration
Key Finding
A simple diagnostic test using GHRP-2 in adult GH deficiency
Healthy subjects + adults with suspected/severe GHD
100 µg
IV
Single provocative test
Acute; samples over 2 h
GHRP-2 produced a measurable GH response and showed useful diagnostic performance in the studied protocol.
GHRP-2 and GH secretion in healthy adults
Healthy adults
1 µg/kg
IV bolus
Single administration
Acute
GHRP-2 substantially stimulated GH release in the experimental setting.
GHRP-2 and GHRH in healthy volunteers
Healthy non-obese men
1 µg/kg
IV bolus
Single administration
Acute
GHRP-2 increased GH and showed greater GH exposure than the GHRH-only condition in the study.
Five-day GHRP-2 study
Healthy young men
100 µg/day
Subcutaneous
Daily
5 days
GH response attenuation was observed and the study did not demonstrate stimulation of IGF-I secretion.
GHRP-2 and food intake study
Lean healthy men
1 µg/kg/h
Subcutaneous infusion
Continuous during study
270 minutes
GHRP-2 increased food intake in the acute experimental setting.
Intranasal GHRP-2 growth study
Prepubertal children with GH deficiency
50–200 µg depending on body weight and study group
Intranasal
Twice daily
48 weeks
Increased endogenous GH secretion did not translate into a significant growth benefit in the studied protocol.
Do not convert this table into a protocol. Route, dose, frequency, participant population, formulation, monitoring, and study objective varied between experiments.
Preclinical / Mechanistic Evidence
Preclinical Research
GHRP-2 belongs to a broader family of growth hormone secretagogues studied across animal and cellular systems. Preclinical research has helped establish the importance of the GHS-R pathway in GH secretion and related physiological processes.
Animal Research
Animal studies of GHRP and GHS-R signaling have contributed to understanding the relationship between secretagogue signaling, GH release, appetite, and energy homeostasis.
Cellular / Receptor Research
Molecular studies have characterized the growth hormone secretagogue receptor as a G-protein-coupled receptor involved in the signaling effects of ghrelin and synthetic secretagogues.
Evidence hierarchy: mechanistic or animal findings can help explain how GHRP-2 may work, but they should not be presented as evidence of a human therapeutic benefit.
Concentration Science
GHRP-2 Research Reconstitution & Concentration
Reconstitution mathematics is separate from clinical dosing. If a research vial contains a known quantity of GHRP-2, the concentration after adding liquid can be calculated from the quantity and final liquid volume.
Concentration = Total Vial Quantity ÷ Liquid Volume
Example 1
Hypothetical vial: 5 mg
Liquid volume: 2 mL
5 ÷ 2 = 2.5 mg/mL
Example 2
Hypothetical vial: 10 mg
Liquid volume: 3 mL
10 ÷ 3 = 3.33 mg/mL
Example 3
Hypothetical vial: 10 mg
Liquid volume: 5 mL
10 ÷ 5 = 2 mg/mL
Important: the examples above calculate concentration only. They do not establish that any particular concentration is appropriate for human use, animal experiments, or a particular research protocol.
BAC Water vs. GHRP-2 Concentration
↑
More Liquid
More liquid produces a lower mathematical concentration when the total peptide quantity remains constant.
↓
Less Liquid
Less liquid produces a higher mathematical concentration when the total peptide quantity remains constant.
=
Total Peptide
Changing the liquid volume does not change the amount of peptide originally contained in the vial.
BAC water is not synonymous with a research protocol. Whether bacteriostatic water is an appropriate diluent depends on the specific product, formulation, intended research application, and applicable documentation. The sources reviewed for this page do not establish a universal GHRP-2 BAC-water instruction.
GHRP-2 has a substantial history of experimental human research, but this should not be confused with FDA approval for a therapeutic indication.
FDA / compounding context: FDA materials identify GHRP-2 among bulk drug substances that may present significant safety risks when used in compounded drugs. The FDA's September 29, 2023 entry specifically discusses injectable and nasal GHRP-2 and identifies concerns including immunogenicity related to peptide aggregation and peptide-related impurities, as well as the presence of an unnatural amino acid that complicates peptide characterization.
FDA enforcement materials have also stated that compounded GHRP-2 products were not eligible for certain section 503A exemptions when the relevant requirements were not met, including circumstances involving the absence of an applicable USP/NF monograph, FDA-approved drug component status, or listing on the 503A bulks list.
What the evidence supports
GHRP-2 can stimulate endogenous GH secretion.
Human provocative-testing studies exist.
GHRP-2 interacts with the GH-secretagogue receptor system.
Different routes and study populations have been investigated.
What the evidence does not establish
A universal GHRP-2 reconstitution volume.
A universal human treatment dose.
A universal post-reconstitution stability period.
That community protocols are clinical recommendations.
No clinically established general-purpose human dose: although specific doses have been investigated in clinical research, no single universally applicable GHRP-2 dose should be inferred from the studies summarized on this page.
Quick Answers
Frequently Asked Questions About GHRP-2
How much BAC water should be added to GHRP-2?
There is no universal GHRP-2 BAC-water volume established by the authoritative sources reviewed. The required liquid volume depends on the actual peptide quantity and the target concentration for the applicable research protocol.
How much BAC water for 5 mg GHRP-2?
For mathematical illustration only, 5 mg divided by 1 mL equals 5 mg/mL, 2 mL equals 2.5 mg/mL, 2.5 mL equals 2 mg/mL, and 5 mL equals 1 mg/mL. These are concentration calculations, not reconstitution recommendations.
How much BAC water for 10 mg GHRP-2?
Mathematically, 10 mg in 1 mL equals 10 mg/mL; 2 mL equals 5 mg/mL; 2.5 mL equals 4 mg/mL; 3 mL equals approximately 3.33 mg/mL; and 5 mL equals 2 mg/mL.
What is the formula for GHRP-2 concentration?
Concentration equals total vial quantity divided by liquid volume. For example, 10 mg ÷ 2 mL = 5 mg/mL.
Does adding more BAC water make GHRP-2 weaker?
In concentration terms, yes. More liquid distributes the same total quantity of peptide through a larger volume, resulting in a lower concentration.
Does adding less BAC water increase GHRP-2 concentration?
Mathematically, yes. Holding the total peptide quantity constant, a smaller liquid volume results in a higher concentration.
Is GHRP-2 FDA approved?
The FDA materials reviewed do not establish an FDA-approved GHRP-2 drug product. FDA has instead discussed GHRP-2 in the context of compounding and identified specific safety and characterization concerns.
Is GHRP-2 the same as growth hormone?
No. GHRP-2 is a synthetic growth hormone secretagogue that can stimulate endogenous GH release. It is not recombinant human growth hormone itself.
Is GHRP-2 the same as GHRH?
No. GHRP-2 and GHRH are different signaling molecules that can influence GH secretion through different receptor systems.
Are published GHRP-2 research doses recommendations?
No. Published doses describe the parameters of individual experiments. They should not be converted into general treatment, self-administration, or reconstitution recommendations.
Does BacScience recommend a GHRP-2 human dose?
No. This page is an educational research resource and does not prescribe or recommend a human dose.
PubMed — A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. PMID: 17609397. Human study evaluating GHRP-2 as a GH provocative test.
PubMed — GH responses to intravenous bolus infusions of GHRH and GHRP-2 separately and in combination in adult volunteers. PMID: 7586605. Human endocrine physiology study.
PubMed — A five day treatment with daily subcutaneous injections of growth hormone-releasing peptide-2 causes response attenuation and does not stimulate IGF-I secretion in healthy young men. PMID: 9820615.
PubMed — Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. PMID: 15699539.
PubMed — Increased secretion of endogenous GH after treatment with an intranasal GH-releasing peptide-2 spray does not promote growth in short children with GH deficiency. PMID: 25374440.
PubMed — The growth hormone secretagogue receptor: intracellular signaling and regulation. PMID: 24651458. Review of GHS-R biology and signaling.
FDA — Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. FDA listing for GHRP-2 discusses injectable and nasal administration, immunogenicity concerns, peptide-related impurities, aggregation, and characterization complexity.
FDA — ImprimisRx CA, Inc. warning letter. FDA enforcement document discussing compounded GHRP-2 and the conditions associated with section 503A exemptions.
Source policy: this page prioritizes FDA and PubMed/NIH sources. Vendor claims, community protocols, social-media posts, and anecdotal reports are not used to establish clinical efficacy, dosing, or regulatory status.
Last Scientifically Reviewed
Date: September 10, 2026
Review scope: GHRP-2 identity, mechanism, human research, concentration mathematics, BAC-water language, and FDA/regulatory information.
